The consensus is bullish on C4 Therapeutics, with increased ...
The consensus is bullish on C4 Therapeutics, with increased forecasts and a higher price target. However, potential flags include dilutive stock issuance over the past year.
Analysts Just Made A Noticeable Upgrade To Their C4 Therapeutics, Inc. (NASDAQ:CCCC) Forecasts
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3177Followers
0Following
7930Visitors
Follow